References

A., Copeland R. 2005. “Evaluation of Enzyme Inhibitors in Drug Discovery. A Guide for Medicinal Chemists and Pharmacologists.” Methods of Biochemical Analysis 46: 1–265.

Abella, Anna, Luc Marti, Marta Camps, Marc Claret, J. Fernández-Alvarez, Ramon Gomis, Anna Gumà, et al. 2003. “Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein-1 Activity Exerts an Antidiabetic Action in Goto-Kakizaki Rats.” Diabetes 52 (April): 1004–13. https://doi.org/10.2337/DIABETES.52.4.1004.

An, Yu A., and Philipp E. Scherer. 2020. “Mouse Adipose Tissue Protein Extraction.” Bio-Protocol 10 (June). https://doi.org/10.21769/BIOPROTOC.3631.

Arvilommi, Anna Maija, Marko Salmi, and Sirpa Jalkanen. 1997. “Organ-Selective Regulation of Vascular Adhesion Protein-1 Expression in Man.” European Journal of Immunology 27 (July): 1794–1800. https://doi.org/10.1002/EJI.1830270730.

BARRAND, MARGERY A., SHEILA A. FOX, and BRIAN A. CALLINGHAM. 1984. “Amine Oxidase Activities in Brown Adipose Tissue of the Rat: Identification of Semicarbazide‐sensitive (Clorgyline‐resistant) Activity at the Fat Cell Membrane.” Journal of Pharmacy and Pharmacology 36: 652–58. https://doi.org/10.1111/j.2042-7158.1984.tb04837.x.

Barrant, M. A., and B. A. Callingham. 1984. “Solubilization and Some Properties of a Semicarbazide-Sensitive Amine Oxidase in Brown Adipose Tissue of the Rat.” The Biochemical Journal 222: 467–75. https://doi.org/10.1042/BJ2220467.

Belligoli, Anna, Chiara Compagnin, Marta Sanna, Francesca Favaretto, Roberto Fabris, Luca Busetto, Mirto Foletto, et al. 2019. “Characterization of Subcutaneous and Omental Adipose Tissue in Patients with Obesity and with Different Degrees of Glucose Impairment.” Scientific Reports 9 (August): 11333. https://doi.org/10.1038/S41598-019-47719-Y.

Blondin, Denis P., Soren Nielsen, Eline N. Kuipers, Mai C. Severinsen, Verena H. Jensen, Stéphanie Miard, Naja Z. Jespersen, et al. 2020. “Human Brown Adipocyte Thermogenesis Is Driven by Β2-AR Stimulation.” Cell Metabolism 32 (August): 287–300.e7. https://doi.org/10.1016/J.CMET.2020.07.005.

Boomsma, F., P. J. De Kam, G. Tjeerdsma, A. H. Van Den Meiracker, and D. J. Van Veldhuisen. 2000. “Plasma Semicarbazide-Sensitive Amine Oxidase (SSAO) Is an Independent Prognostic Marker for Mortality in Chronic Heart Failure.” European Heart Journal 21: 1859–63. https://doi.org/10.1053/EUHJ.2000.2176.

Börgeson, Emma, Jeremie Boucher, and Carolina E. Hagberg. 2022. “Of Mice and Men: Pinpointing Species Differences in Adipose Tissue Biology.” Frontiers in Cell and Developmental Biology 10 (September): 1003118. https://doi.org/10.3389/FCELL.2022.1003118/BIBTEX.

Bour, Sandy, Sylvie Caspar-Bauguil, Zsuzsa Iffiú-Soltész, Maryse Nibbelink, Béatrice Cousin, Mari Miiluniemi, Marko Salmi, et al. 2009. “Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein-1 Deficiency Reduces Leukocyte Infiltration into Adipose Tissue and Favors Fat Deposition.” The American Journal of Pathology 174: 1075–83. https://doi.org/10.2353/AJPATH.2009.080612.

Cai, Limeng, Yuqi Wang, Ying Yang, and Hao Wu. 2022. “A Low-Cost, Enzyme-Coupled Fluorescent Assay for Rapid Quantification of Glycolysis Rate of Cells.” Analytical and Bioanalytical Chemistry 414 (February): 1987–97. https://doi.org/10.1007/S00216-021-03834-2/METRICS.

Carpéné, Christian, Nathalie Boulet, Alice Chaplin, and Josep Mercader. 2019. “Past, Present and Future Anti-Obesity Effects of Flavin-Containing and/or Copper-Containing Amine Oxidase Inhibitors.” Medicines (Basel, Switzerland) 6 (January): 9. https://doi.org/10.3390/MEDICINES6010009.

Chait, Alan, and Laura J. den Hartigh. 2020. “Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease.” Frontiers in Cardiovascular Medicine 7 (February). https://doi.org/10.3389/FCVM.2020.00022.

Che, Baoquan, Lin Wang, Zhe Zhang, Yongqian Zhang, and Yulin Deng. 2012. “Distribution and Accumulation of Caffeine in Rat Tissues and Its Inhibition on Semicarbazide-Sensitive Amine Oxidase.” NeuroToxicology 33 (October): 1248–53. https://doi.org/10.1016/J.NEURO.2012.07.004.

Chew, Nicholas W. S., Cheng Han Ng, Darren Jun Hao Tan, Gwyneth Kong, Chaoxing Lin, Yip Han Chin, Wen Hui Lim, et al. 2023. “The Global Burden of Metabolic Disease: Data from 2000 to 2019.” Cell Metabolism 35 (March): 414–428.e3. https://doi.org/10.1016/j.cmet.2023.02.003.

Chusyd, Daniella E., Donghai Wang, Derek M. Huffman, and Tim R. Nagy. 2016. “Relationships Between Rodent White Adipose Fat Pads and Human White Adipose Fat Depots.” Frontiers in Nutrition 3 (April). https://doi.org/10.3389/FNUT.2016.00010.

Danielli, Marianna, Roisin Clare Thomas, Lauren Marie Quinn, and Bee Kang Tan. 2022. “Vascular Adhesion Protein-1 (VAP-1) in Vascular Inflammatory Diseases: A Narrative Review.” Vasa - European Journal of Vascular Medicine 51 (November): 341–50. https://doi.org/10.1024/0301-1526/a001031.

Dezse, K. E., W. P. Frank, and C. A. C. Baptista. 2020. “Fat Removal During Acetone Dehydration and Defatting Phases of Plastination.” Journal of Plastination 32: 26–30. https://doi.org/10.56507/MBJO3692.

Dunkel, P., A. Gelain, D. Barlocco, N. Haider, K. Gyires, B. Sperlagh, K. Magyar, E. Maccioni, A. Fadda, and P. Matyus. 2008. “Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein 1: Recent Developments Concerning Substrates and Inhibitors of a Promising Therapeutic Target.” Current Medicinal Chemistry 15 (July): 1827–39. https://doi.org/10.2174/092986708785133022.

Hernandez-Guillamon, Mar, Lidia Garcia-Bonilla, Montse Solé, Victoria Sosti, Mireia Parés, Mireia Campos, Arantxa Ortega-Aznar, et al. 2010. “Plasma VAP-1/SSAO Activity Predicts Intracranial Hemorrhages and Adverse Neurological Outcome After Tissue Plasminogen Activator Treatment in Stroke.” Stroke 41: 1528–35. https://doi.org/10.1161/STROKEAHA.110.584623.

Iglesias-Osma, Maria Carmen, Sandy Bour, Maria Jose Garcia-Barrado, Virgile Visentin, Maria Francisca Pastor, Xavier Testar, Luc Marti, et al. 2005. “Methylamine but Not Mafenide Mimics Insulin-Like Activity of the Semicarbazide-Sensitive Amine Oxidase-Substrate Benzylamine on Glucose Tolerance and on Human Adipocyte Metabolism.” Pharmacological Research 52 (December): 475–84. https://doi.org/10.1016/J.PHRS.2005.07.008.

Iglesias-Osma, María Carmen, Maria José Garcia-Barrado, Virgile Visentin, Maria Francisca Pastor-Mansilla, Sandy Bour, Daníelle Prévot, Philippe Valet, Julio Moratinos, and Christian Carpéné. 2004. “Benzylamine Exhibits Insulin-Like Effects on Glucose Disposal, Glucose Transport, and Fat Cell Lipolysis in Rabbits and Diabetic Mice.” The Journal of Pharmacology and Experimental Therapeutics 309 (June): 1020–28. https://doi.org/10.1124/JPET.103.063636.

Jarnicki, A. G., H. Schilter, G. Liu, K. Wheeldon, A. T. Essilfie, J. S. Foot, T. T. Yow, W. Jarolimek, and Philip M. Hansbro. 2016. “The Inhibitor of Semicarbazide-Sensitive Amine Oxidase, PXS-4728A, Ameliorates Key Features of Chronic Obstructive Pulmonary Disease in a Mouse Model.” British Journal of Pharmacology 173: 3161–75. https://doi.org/10.1111/bph.13573.

Karakuzu, Ozgur, Melissa R. Cruz, Yi Liu, and Danielle A. Garsin. 2019. “Amplex Red Assay for Measuring Hydrogen Peroxide Production from Caenorhabditis Elegans.” Bio-Protocol 9 (November). https://doi.org/10.21769/BIOPROTOC.3409.

Kurkijarvi, Riikka, Gennady G. Yegutkin, Bridget K. Gunson, Sirpa Jalkanen, Marko Salmi, and David H. Adams. 2000. “Circulating Soluble Vascular Adhesion Protein 1 Accounts for the Increased Serum Monoamine Oxidase Activity Chronic Liver Disease.” Gastroenterology 119: 1096–1103. https://doi.org/10.1053/gast.2000.18163.

Li, Chaosheng, Zhenhua Wang, Xiaoli Li, and Jun Chen. 2019. “Effects of Semicarbazide-Sensitive Amine Oxidase Inhibitors on Morphology of Aorta and Kidney in Diabetic Rats.” BMC Endocrine Disorders 19 (June). https://doi.org/10.1186/S12902-019-0392-1.

Li, Hui, Shiyu Du, Panpan Niu, Xiaosong Gu, Jun Wang, and Ying Zhao. 2021. “Vascular Adhesion Protein-1 (VAP-1)/Semicarbazide-Sensitive Amine Oxidase (SSAO): A Potential Therapeutic Target for Atherosclerotic Cardiovascular Diseases.” Frontiers in Pharmacology 12 (July). https://doi.org/10.3389/FPHAR.2021.679707.

Lyles, G. A. 1995. “Substrate-Specificity of Mammalian Tissue-Bound Semicarbazide-Sensitive Amine Oxidase.” Progress in Brain Research 106: 293–303. https://doi.org/10.1016/s0079-6123(08)61226-1.

Ma, Qingyi, Anatol Manaenko, Nikan H. Khatibi, Wanqiu Chen, John H. Zhang, and Jiping Tang. 2011. “Vascular Adhesion Protein-1 Inhibition Provides Antiinflammatory Protection After an Intracerebral Hemorrhagic Stroke in Mice.” Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism 31: 881–93. https://doi.org/10.1038/JCBFM.2010.167.

Manasieva, Vesna, Shori Thakur, Lisa A. Lione, Anwar R. Baydoun, and John Skamarauskas. 2023. “The Impact of Semicarbazide Sensitive Amine Oxidase Activity on Rat Aortic Vascular Smooth Muscle Cells.” International Journal of Molecular Sciences 2023, Vol. 24, Page 4946 24 (March): 4946. https://doi.org/10.3390/IJMS24054946.

Manasieva, Vesna, Shori Thakur, Lisa A. Lione, Jessal Patel, Anwar Baydoun, and John Skamarauskas. 2022. “Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells.” Biomolecules 12 (November). https://doi.org/10.3390/BIOM12111563.

Marin, R. Diaz, S. Crespo-Garcia, Ariel Molly Wilson, and P. Sapieha. 2019. “RELi Protocol: Optimization for Protein Extraction from White, Brown and Beige Adipose Tissues.” MethodsX 6 (January): 918–28. https://doi.org/10.1016/J.MEX.2019.04.010.

Mercader, Josep, Zsuzsa Iffiú-Soltész, Sandy Bour, and Christian Carpéné. 2011. “Oral Administration of Semicarbazide Limits Weight Gain Together with Inhibition of Fat Deposition and of Primary Amine Oxidase Activity in Adipose Tissue.” Journal of Obesity 2011 (January): 475786. https://doi.org/10.1155/2011/475786.

Murata, Miyuki, Kousuke Noda, Akiko Kawasaki, Shiho Yoshida, Yoko Dong, Michiyuki Saito, Zhenyu Dong, et al. 2017. “Soluble Vascular Adhesion Protein-1 Mediates Spermine Oxidation as Semicarbazide-Sensitive Amine Oxidase: Possible Role in Proliferative Diabetic Retinopathy.” Current Eye Research 42 (December): 1674–83. https://doi.org/10.1080/02713683.2017.1359847.

Noble, James E., and Marc J. A. Bailey. 2009. “Chapter 8 Quantitation of Protein.” Methods in Enzymology 463 (January): 73–95. https://doi.org/10.1016/S0076-6879(09)63008-1.

Obata, Toshio. 2006. “Diabetes and Semicarbazide-Sensitive Amine Oxidase (SSAO) Activity: A Review.” Life Sciences 79 (June): 417–22. https://doi.org/10.1016/j.lfs.2006.01.017.

Pannecoeck, Roos, Daphne Serruys, Lara Benmeridja, Joris R. Delanghe, Nanja Van Geel, Reinhart Speeckaert, and Marijn M. Speeckaert. 2015. “Vascular Adhesion Protein-1: Role in Human Pathology and Application as a Biomarker.” Critical Reviews in Clinical Laboratory Sciences 52: 284–300. https://doi.org/10.3109/10408363.2015.1050714.

Papukashvili, Dimitri, Nino Rcheulishvili, and Yulin Deng. 2020. “Attenuation of Weight Gain and Prevention of Associated Pathologies by Inhibiting SSAO.” Nutrients 12. https://doi.org/10.3390/NU12010184.

Peng, Ya, Jun Wang, Miao Zhang, Panpan Niu, Mengya Yang, Yilin Yang, and Ying Zhao. 2016. “Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle Cells.” PloS One 11 (April). https://doi.org/10.1371/JOURNAL.PONE.0152758.

Reddy, Vundrala Sumedha, S. Shiva, Srinidhi Manikantan, and Seeram Ramakrishna. 2024. “Pharmacology of Caffeine and Its Effects on the Human Body.” European Journal of Medicinal Chemistry Reports 10 (April): 100138. https://doi.org/10.1016/J.EJMCR.2024.100138.

Salmi, Marko, and Sirpa Jalkanen. 1992. “A 90-Kilodalton Endothelial Cell Molecule Mediating Lymphocyte Binding in Humans.” Science (New York, N.Y.) 257 (September): 1407–9. https://doi.org/10.1126/SCIENCE.1529341.

———. 2019. “Vascular Adhesion Protein-1: A Cell Surface Amine Oxidase in Translation.” Antioxidants & Redox Signaling 30 (January): 314. https://doi.org/10.1089/ARS.2017.7418.

Salmi, Marko, Sami Tohka, and Sirpa Jalkanen. 2000. “Human Vascular Adhesion Protein-1 (VAP-1) Plays a Critical Role in Lymphocyte-Endothelial Cell Adhesion Cascade Under Shear.” Circulation Research 86 (June): 1245–51. https://doi.org/10.1161/01.RES.86.12.1245.

Schilter, Heidi C., Adam Collison, Remo C. Russo, Jonathan S. Foot, Tin T. Yow, Angelica T. Vieira, Livia D. Tavares, Joerg Mattes, Mauro M. Teixeira, and Wolfgang Jarolimek. 2015. “Effects of an Anti-Inflammatory VAP-1/SSAO Inhibitor, PXS-4728A, on Pulmonary Neutrophil Migration.” Respiratory Research 16 (March). https://doi.org/10.1186/S12931-015-0200-Z.

Silvola, Johanna M. U., Helena Virtanen, Riikka Siitonen, Sanna Hellberg, Heidi Liljenbäck, Olli Metsälä, Mia Ståhle, et al. 2016. “Leukocyte Trafficking-Associated Vascular Adhesion Protein 1 Is Expressed and Functionally Active in Atherosclerotic Plaques.” Scientific Reports 6 (October). https://doi.org/10.1038/SREP35089.

Stevanato, Roberto, Sara Cardillo, Michele Braga, Angela De Iuliis, Valentina Battaglia, Antonio Toninello, Enzo Agostinelli, and Fabio Vianello. 2011. “Preliminary Kinetic Characterization of a Copper Amine Oxidase from Rat Liver Mitochondria Matrix.” Amino Acids 40: 713–20. https://doi.org/10.1007/S00726-010-0708-Y.

Sun, Ping, Mar Hernandez-Guillamón, Mireia Campos-Martorell, Alba Simats, Joan Montaner, Mercedes Unzeta, and Montse Solé. 2018. “Simvastatin Blocks Soluble SSAO/VAP-1 Release in Experimental Models of Cerebral Ischemia: Possible Benefits for Stroke-Induced Inflammation Control.” Biochimica Et Biophysica Acta. Molecular Basis of Disease 1864 (February): 542–53. https://doi.org/10.1016/J.BBADIS.2017.11.014.

Tábi, Tamás, Éva Szöko, Anita Mérey, Veronika Tóth, Péter Mátyus, and Klára Gyires. 2013. “Study on SSAO Enzyme Activity and Anti-Inflammatory Effect of SSAO Inhibitors in Animal Model of Inflammation.” Journal of Neural Transmission (Vienna, Austria : 1996) 120 (June): 963–67. https://doi.org/10.1007/S00702-012-0961-1.

Toiyama, Yuji, Chikao Miki, Yasuhiro Inoue, Aya Kawamoto, and Masato Kusunoki. 2009. “Circulating Form of Human Vascular Adhesion Protein-1 (VAP-1): Decreased Serum Levels in Progression of Colorectal Cancer and Predictive Marker of Lymphatic and Hepatic Metastasis.” Journal of Surgical Oncology 99 (May): 368–72. https://doi.org/10.1002/jso.21246.

Unzeta, Mercedes, Mar Hernàndez-Guillamon, Ping Sun, and Montse Solé. 2021. “SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer’s Disease.” International Journal of Molecular Sciences 2021, Vol. 22, Page 3365 22 (March): 3365. https://doi.org/10.3390/IJMS22073365.

Wang, Shu Huei, Tse Ya Yu, Feng Chiao Tsai, Chris J. Weston, Mao Shin Lin, Chi Sheng Hung, Hsien Li Kao, et al. 2018. “Inhibition of Semicarbazide-Sensitive Amine Oxidase Reduces Atherosclerosis in Apolipoprotein e-Deficient Mice.” Translational Research 197 (July): 12–31. https://doi.org/10.1016/j.trsl.2018.03.001.

Xu, Hao Liang, Maggie Garcia, Fernando Testai, Francesco Vetri, Alexandra Barabanova, Dale A. Pelligrino, and Chanannait Paisansathan. 2014. “Pharmacologic Blockade of Vascular Adhesion Protein-1 Lessens Neurologic Dysfunction in Rats Subjected to Subarachnoid Hemorrhage.” Brain Research 1586 (October): 83–89. https://doi.org/10.1016/J.BRAINRES.2014.08.036.

Yan, Liben, Chunli Sun, Yaxi Zhang, Peng Zhang, Yu Chen, Yifan Deng, Tianyi Er, Yulin Deng, Zhimin Wang, and Hong Ma. 2023. “The Biological Implication of Semicarbazide-Sensitive Amine Oxidase (SSAO) Upregulation in Rat Systemic Inflammatory Response Under Simulated Aerospace Environment.” International Journal of Molecular Sciences 24 (February): 3666. https://doi.org/10.3390/IJMS24043666/S1.

Yang, Wei, Hui Li, Hongjun Luo, and Wenhong Luo. 2011. “Inhibition of Semicarbazide-Sensitive Amine Oxidase Attenuates Myocardial Ischemia-Reperfusion Injury in an in Vivo Rat Model.” Life Sciences 88 (February): 302–6. https://doi.org/10.1016/J.LFS.2010.12.003.

Yasuda, Hiromi, Yuji Toiyama, Masaki Ohi, Yasuhiko Mohri, Chikao Miki, and Masato Kusunoki. 2011. “Serum Soluble Vascular Adhesion Protein-1 Is a Valuable Prognostic Marker in Gastric Cancer.” Journal of Surgical Oncology 103 (June): 695–99. https://doi.org/10.1002/jso.21877.

Yraola, Francesc, Silvia García-Vicente, Luc Marti, Fernando Albericio, Antonio Zorzano, and Miriam Royo. 2007. “Understanding the Mechanism of Action of the Novel SSAO Substrate (C7NH10)6(V10O28)·2H2O, a Prodrug of Peroxovanadate Insulin Mimetics.” Chemical Biology & Drug Design 69 (June): 423–28. https://doi.org/10.1111/J.1747-0285.2007.00516.X.

Yu, P. H., and Y. L. Deng. 1998. “Endogenous Formaldehyde as a Potential Factor of Vulnerability of Atherosclerosis: Involvement of Semicarbazide-Sensitive Amine Oxidase-Mediated Methylamine Turnover.” Atherosclerosis 140 (October): 357–63. https://doi.org/10.1016/S0021-9150(98)00142-7.

Yu, Peter H., Michael Wang, Hui Fan, Yulin Deng, and Diana Gubisne-Haberle. 2004. “Involvement of SSAO-Mediated Deamination in Adipose Glucose Transport and Weight Gain in Obese Diabetic KKAy Mice.” American Journal of Physiology - Endocrinology and Metabolism 286 (April). https://doi.org/10.1152/AJPENDO.00272.2003.

Yu, P., M. Wang, Y. Deng, H. Fan, and L. Shira-Bock. 2002. “Involvement of Semicarbazide-Sensitive Amine Oxidase-Mediated Deamination in Atherogenesis in KKAy Diabetic Mice Fed with High Cholesterol Diet.” Diabetologia 45: 1255–62. https://doi.org/10.1007/S00125-002-0903-9.

Zhang, Miao, Limin Liu, Feng Zhi, Panpan Niu, Mengya Yang, Xuemei Zhu, Ying Diao, Yanmei Li, Jun Wang, and Ying Zhao. 2016. “Inactivation of Semicarbazide-Sensitive Amine Oxidase Induces the Phenotypic Switch of Smooth Muscle Cells and Aggravates the Development of Atherosclerotic Lesions.” Atherosclerosis 249 (June): 76–82. https://doi.org/10.1016/J.ATHEROSCLEROSIS.2016.03.039.

Zorzano, Antonio, Anna Abella, Luc Marti, Christian Carpéné, Manuel Palacín, and Xavier Testar. 2003. “Semicarbazide-Sensitive Amine Oxidase Activity Exerts Insulin-Like Effects on Glucose Metabolism and Insulin-Signaling Pathways in Adipose Cells.” Biochimica Et Biophysica Acta - Proteins and Proteomics 1647 (April): 3–9. https://doi.org/10.1016/S1570-9639(03)00039-6.